Yuka Kasamatsu

Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial

Masakazu Abé, Yasuyuki Hirashima, Yuka Kasamatsu et al. · Supportive Care in Cancer · 2015 · 69 citations

Medicine, Pharmacology, Pharmacotherapy +16

Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy

Munetaka Takekuma, Yuka Kasamatsu, Nobuhiro Kado et al. · International Journal of Clinical Oncology · 2016 · 40 citations

Medicine, Oncology, Surgery +17

Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary

Etsuko Miyagi, Noriaki Arakawa, Kentaro Sakamaki et al. · International Journal of Clinical Oncology · 2021 · 34 citations · Full text

Medicine, Gynecology, Oncology +17

Reconsideration of postoperative concurrent chemoradiotherapy with fluorouracil and cisplatin for uterine cervical cancer

Munetaka Takekuma, Yuka Kasamatsu, Nobuhiro Kado et al. · Journal of obstetrics and gynaecology research · 2015 · 18 citations

Medicine, Oncology, Surgery +17

Efficacy of Olanzapine Combined Therapy for Patients Receiving Highly Emetogenic Chemotherapy Resistant to Standard Antiemetic Therapy

Masakazu Abé, Yuka Kasamatsu, Nobuhiro Kado et al. · BioMed Research International · 2015 · 17 citations · Full text

Medicine, Oncology, Pharmacotherapy +17